UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

HDAC activity is required for efficient core promoter function at the mouse mammary tumor virus promoter

BioMed research international, 2011-01, Vol.2011 (1), p.416905

2011

Volltextzugriff (PDF)

37PPlasma ctDNA RAS mutation analysis by digital polymerase chain reaction in patients with inoperable pancreatic cancer

Annals of oncology, 2019-11, Vol.30 (Supplement_7)

2019

Volltextzugriff (PDF)

Plasma ctDNA RAS mutation analysis by digital polymerase chain reaction in patients with inoperable pancreatic cancer

Annals of oncology, 2019-11, Vol.30, p.vii12

2019

Volltextzugriff (PDF)

P-181 Role of detection and quantification of plasma ctDNA RAS mutations by BEAMing digital PCR in patients with locally advanced and metastatic pancreatic cancer

Annals of oncology, 2020-07, Vol.31, p.S149

2020

Volltextzugriff (PDF)

P-264 Clinical validation of next-generation sequencing as a liquid biopsy for the monitoring of patients with metastatic colorectal cancer

Annals of oncology, 2020-07, Vol.31, p.S176

2020

Volltextzugriff (PDF)

P-173 Customisation of therapeutic strategy in metastatic colorectal cancer by use of liquid biopsies: Final results of an observational study

Annals of oncology, 2021-07, Vol.32, p.S158-S159

2021

Volltextzugriff (PDF)

The androgen-regulated gene human kallikrein 15 ( ) is an independent and favourable prognostic marker for breast cancer

British journal of cancer, 2002-11, Vol.87 (11), p.1294-1300

2002

Volltextzugriff (PDF)

Customisation of therapeutic strategy in metastatic colorectal cancer by use of liquid biopsies: Updated results of an observational study

Annals of oncology, 2019-11, Vol.30, p.vii13

2019

Volltextzugriff (PDF)

41PCustomisation of therapeutic strategy in metastatic colorectal cancer by use of liquid biopsies: Updated results of an observational study

Annals of oncology, 2019-11, Vol.30 (Supplement_7)

2019

Volltextzugriff (PDF)

Biochemical and Enzymatic Characterization of Human Kallikrein 5 (hK5), a Novel Serine Protease Potentially Involved in Cancer Progression

The Journal of biological chemistry, 2005-04, Vol.280 (15), p.14628-14635

2005

Volltextzugriff (PDF)

Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions

British journal of cancer, 2000-01, Vol.82 (2), p.361-367

2000

Volltextzugriff (PDF)

Characterization of the enzymatic activity of human kallikrein 6: autoactivation, substrate specificity, and regulation by inhibitors

Biochemical and biophysical research communications, 2003-08, Vol.307 (4), p.948-955

2003

Volltextzugriff (PDF)

The New Human Kallikrein Gene Family: Implications in Carcinogenesis

Trends in Endocrinology & Metabolism, 2000-03, Vol.11 (2), p.54-60

2000

Volltextzugriff (PDF)

The human KLK8 (Neuropsin/Ovasin) gene : Identification of two novel splice variants and its prognostic value in ovarian cancer

Clinical cancer research, 2001-04, Vol.7 (4), p.806-811

2001

Volltextzugriff (PDF)

KLK12 Is a Novel Serine Protease and a New Member of the Human Kallikrein Gene Family—Differential Expression in Breast Cancer

Genomics (San Diego, Calif.), 2000-11, Vol.69 (3), p.331-341

2000

Volltextzugriff (PDF)

The Combination of Human Glandular Kallikrein and Free Prostate-specific Antigen (PSA) Enhances Discrimination Between Prostate Cancer and Benign Prostatic Hyperplasia in Patients with Moderately Increased Total PSA

Clinical chemistry (Baltimore, Md.), 1999-11, Vol.45 (11), p.1960-1966

1999

Volltextzugriff (PDF)

Characterization of androgen receptor and nuclear receptor co‐regulator expression in human breast cancer cell lines exhibiting differential regulation of kallikreins 2 and 3

International journal of cancer, 2002-08, Vol.100 (5), p.507-514

2002

Volltextzugriff (PDF)

Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue

Urology (Ridgewood, N.J.), 2000-09, Vol.56 (3), p.527-532

2000

Volltextzugriff (PDF)

Cloning of a new member of the human kallikrein gene family, KLK14, which is down-regulated in different malignancies

Cancer research (Chicago, Ill.), 2001-04, Vol.61 (8), p.3425-3431

2001

Volltextzugriff (PDF)

The KLK7 ( PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme is a new member of the human kallikrein gene family — genomic characterization, mapping, tissue expression and hormonal regulation

Gene, 2000-08, Vol.254 (1), p.119-128

2000

Volltextzugriff (PDF)

Serum Human Glandular Kallikrein-2 Protease Levels Predict the Presence of Prostate Cancer Among Men With Elevated Prostate-Specific Antigen

Journal of clinical oncology, 2000-03, Vol.18 (5), p.1036-1042

2000

Volltextzugriff (PDF)

Differential steroid hormone regulation of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) in breast cancer cell lines

Breast cancer research and treatment, 2000-02, Vol.59 (3), p.263-270

2000

Volltextzugriff (PDF)

Association of kallikrein expression in nipple aspirate fluid with breast cancer risk

International journal of cancer, 2004-02, Vol.108 (4), p.588-591

2004

Volltextzugriff (PDF)

Complex formation between human kallikrein 13 and serum protease inhibitors

Clinica chimica acta, 2004, Vol.339 (1), p.157-167

2004

Volltextzugriff (PDF)

Development of an Ultrasensitive Immunoassay for Human Glandular Kallikrein with No Cross-Reactivity from Prostate-specific Antigen

Clinical chemistry (Baltimore, Md.), 1999-06, Vol.45 (6), p.790-799

1999

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Englisch
(101)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

HDAC activity is required for efficient core promoter function at the mouse mammary tumor virus promoter

37PPlasma ctDNA RAS mutation analysis by digital polymerase chain reaction in patients with inoperable pancreatic cancer

Plasma ctDNA RAS mutation analysis by digital polymerase chain reaction in patients with inoperable pancreatic cancer

P-181 Role of detection and quantification of plasma ctDNA RAS mutations by BEAMing digital PCR in patients with locally advanced and metastatic pancreatic cancer

P-264 Clinical validation of next-generation sequencing as a liquid biopsy for the monitoring of patients with metastatic colorectal cancer

P-173 Customisation of therapeutic strategy in metastatic colorectal cancer by use of liquid biopsies: Final results of an observational study

The androgen-regulated gene human kallikrein 15 ( ) is an independent and favourable prognostic marker for breast cancer

Customisation of therapeutic strategy in metastatic colorectal cancer by use of liquid biopsies: Updated results of an observational study

41PCustomisation of therapeutic strategy in metastatic colorectal cancer by use of liquid biopsies: Updated results of an observational study

Biochemical and Enzymatic Characterization of Human Kallikrein 5 (hK5), a Novel Serine Protease Potentially Involved in Cancer Progression

Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions

Characterization of the enzymatic activity of human kallikrein 6: autoactivation, substrate specificity, and regulation by inhibitors

The New Human Kallikrein Gene Family: Implications in Carcinogenesis

The human KLK8 (Neuropsin/Ovasin) gene : Identification of two novel splice variants and its prognostic value in ovarian cancer

KLK12 Is a Novel Serine Protease and a New Member of the Human Kallikrein Gene Family—Differential Expression in Breast Cancer

The Combination of Human Glandular Kallikrein and Free Prostate-specific Antigen (PSA) Enhances Discrimination Between Prostate Cancer and Benign Prostatic Hyperplasia in Patients with Moderately Increased Total PSA

Characterization of androgen receptor and nuclear receptor co‐regulator expression in human breast cancer cell lines exhibiting differential regulation of kallikreins 2 and 3

Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue

Cloning of a new member of the human kallikrein gene family, KLK14, which is down-regulated in different malignancies

The KLK7 ( PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme is a new member of the human kallikrein gene family — genomic characterization, mapping, tissue expression and hormonal regulation

Serum Human Glandular Kallikrein-2 Protease Levels Predict the Presence of Prostate Cancer Among Men With Elevated Prostate-Specific Antigen

Differential steroid hormone regulation of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) in breast cancer cell lines

Association of kallikrein expression in nipple aspirate fluid with breast cancer risk

Complex formation between human kallikrein 13 and serum protease inhibitors

Development of an Ultrasensitive Immunoassay for Human Glandular Kallikrein with No Cross-Reactivity from Prostate-specific Antigen

Suchergebnisse filtern